Amelie Lothe

Courbevoie, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics.

Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics.

Journal: Epilepsia open
Published: June 08, 2026

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

Journal: Epilepsia open
Published: April 01, 2026

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Journal: Epilepsia
Published: March 13, 2026

Healthcare resource utilization and persistence in children and adults with Dravet syndrome receiving fenfluramine: a retrospective analysis using United States claims data.

Healthcare resource utilization and persistence in children and adults with Dravet syndrome receiving fenfluramine: a retrospective analysis using United States claims data.

Journal: Seizure
Published: January 09, 2026

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.

Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.

Journal: Epilepsy & behavior : E&B
Published: July 18, 2025

Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome.

Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome.

Journal: Epilepsia
Published: December 18, 2024

Comprehensive scoping review of fenfluramine's role in managing generalized tonic-clonic seizures in developmental and epileptic encephalopathies.

Comprehensive scoping review of fenfluramine's role in managing generalized tonic-clonic seizures in developmental and epileptic encephalopathies.

Journal: Epilepsia
Published: February 09, 2024

GABAergic inhibition shapes behavior and neural dynamics in human visual working memory.

GABAergic inhibition shapes behavior and neural dynamics in human visual working memory.

Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: July 13, 2023

Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome.

Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome.

Journal: Epilepsia open
Published: May 03, 2023

Fenfluramine treatment for Dravet syndrome: Caregiver- and clinician-reported benefits on the quality of life of patients, caregivers, and families living in Germany, Spain, Italy, and the United Kingdom.

Fenfluramine treatment for Dravet syndrome: Caregiver- and clinician-reported benefits on the quality of life of patients, caregivers, and families living in Germany, Spain, Italy, and the United Kingdom.

Journal: Epilepsy research
Published: August 04, 2022

EEG parameters as endpoints in epilepsy clinical trials - An expert panel opinion paper.

EEG parameters as endpoints in epilepsy clinical trials - An expert panel opinion paper.

Journal: Epilepsy research
Published: May 09, 2022

An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program.

An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program.

Journal: Epilepsia open
Published: April 08, 2022
Showing 1-12 of 16

Last Updated: 09/26/2026